Finance News – Drug Price
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Tariffs
Stock
Investors
Ceo
Stock Market
Crypto Assets
Ethereum
Cryptocurrency
Price
Markets
Xrp
Eth
Etf
Bse
Earnings
Ipo
Stablecoin
Investment
Blockchain
Revenue
Solana
Index
Trade
Sec
Inflation
Interest Rates
Wall Street
Token
Sensex
Coinbase
Treasury
Federal Reserve
Nasdaq
Traders
Profit
Nse
China
Nifty
Bse Sensex
Sp 500
Investor
Gold
Tesla
Company
Economy
Telecoms
Crypto Majors
Petroineos
Staff Statement
Iht Net
Infiltration Scheme
Prosus
Confirmation
Avalanch
Florida Attorney General
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • Jul 30, 2025
Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure
AstraZeneca’s leadership suggested lowering prices on certain medications in the U.S., aiming to address market challenges and regulatory pressures affecting the company’s revenue...
Read Full Article →
City A.M. • May 12, 2025
GSK and Astrazeneca shares slump as Trump vows drug price cut
The announcement of new executive measures aimed at lowering medication costs has led to a decline in the stock values of major pharmaceutical companies, reflecting investor concer...
Read Full Article →